# FDA Inspection 1140292 - SURGENEX LLC - April 16, 2021

Source: https://www.keypedia.com/records/fda_inspections/surgenex-llc/cb340e36-c0e8-49e2-8e16-428bfb09435a
Source feed: FDA_Inspections

> FDA Inspection 1140292 for SURGENEX LLC on April 16, 2021. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1140292
- Company Name: SURGENEX LLC
- Inspection Date: 2021-04-16
- Classification: Official Action Indicated (OAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1201113 - 2023-03-29](https://www.keypedia.com/records/fda_inspections/surgenex-llc/b77af1ce-3839-4dcd-a1b2-a78fdc08d9ed)
- [FDA Inspection 1201113 - 2023-03-29](https://www.keypedia.com/records/fda_inspections/surgenex-llc/863a3e74-04ef-4e7e-8003-94e223be1c36)
- [FDA Inspection 1201113 - 2023-03-29](https://www.keypedia.com/records/fda_inspections/surgenex-llc/1dba6ee2-f533-4a11-aa32-f881bd501587)
- [FDA Inspection 1140292 - 2021-04-16](https://www.keypedia.com/records/fda_inspections/surgenex-llc/b0956acb-e945-42c6-aeda-d1354c1f3b57)
- [FDA Inspection 1140292 - 2021-04-16](https://www.keypedia.com/records/fda_inspections/surgenex-llc/ad25a13c-8f53-4ec9-b0c9-f6e95da06527)

Company: https://www.keypedia.com/companies/surgenex-llc/7577df14-aa69-4670-89bf-a4e3f4f8d691

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d